FDA Import Refusal 799-0140050-0/20003/1 — HBC Lifesciences Private Limited
The FDA refused shipment 799-0140050-0/20003/1 from HBC Lifesciences Private Limited (India) on Jan 2, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Jan 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDB73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75